Sunisa Thongsom

Sunisa Thongsom

Auto-generated profile, based on publicly available information

Sunisa Thongsom

Soft Matter Nanotechnology Group, CIC biomaGUNE, Basque Research and Technological Alliance, San Sebastian, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2024 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
LDLucrezia Desiderio
Lucrezia Desiderio
NGNatalie Solfried Gjerde
Natalie Solfried Gjerde
ETElisamaria Tasca
Elisamaria Tasca
Luciano GalantiniLuciano Galantini
Luciano Galantini
ILIrantzu Llarena
Irantzu Llarena
MGMauro Giustini
Mauro Giustini
The anticancer drug doxorubicin hydrochloride (DX) shows a high solubility in aqueous media thanks to the positive charge in the ammonium group. This feature, however, affects the drug encapsulation in the hydrophobic domains of polymeric micelles (PMs) used for the targeted delivery of the drug. At basic pH, DX deprotonates but also acquires a negative charge in the phenolic groups of the anthracycline structure. Both the efficiency and the rate of encapsulation will be increased by choosing an appropriate pH such that the drug molecule is in neutral form. An optimal pH for the encapsulation of the DX in PMs based on commercial poloxamers and on the diblock copolymer methoxy-poly(ethylene glycol)17-b-poly(ε-caprolactone)9 was determined by fluorescence spectroscopy, following the time evolution of both the intensity ratio of the first and the second emission bands of DX and its fluorescence lifetime, both sensitive to the environment polarity. Intracellular delivery of PMs encapsulated drug was followed by Confocal Scanning Laser Microscopy (CSLM). Cell viability was assessed with the sulforhodamine B (SRB) assay. By adjusting pH to 8.1 a high yield of incorporation of DX in the PMs was achieved coupled to an appreciable increase (one order of magnitude) in the drug encapsulation rate. In-vitro tests in selected cancer cell lines showed the slow release of the drug and a delay in the cytotoxic response in comparison to free DX as detected by CSLM and SRB assay. The proposed methodology paves the way for a greener, faster and more efficient encapsulation of DX in PMs.

1 December 2025 in Nanoscale
Verified
Journal Article
Open access
PDF file
PDP. Rafael Donnarumma
P. Rafael Donnarumma
MMMicaela A. Macchione
Micaela A. Macchione
FWFranziska Wasner
Franziska Wasner
EKElif Kocar
Elif Kocar
VTVicente Durán Toro
Vicente Durán Toro
SMSergio Moya
Sergio Moya
Magnetic nanodiscs (MNDs), a class of anisotropic magnetite nanomaterials, have attracted considerable attention in smart actuation as they can generate heat through hysteretic losses and their discoidal shape can be tuned to exhibit vortex magnetization and generate mechanical stimuli. Despite near-zero net magnetization, at high concentrations, interparticle forces become dominant leading to MND aggregation. Here, we have optimized a previously reported synthetic approach based on the synthesis of hematite templates subsequently converted into a magnetite phase. We show that removal of oleic acid (OA) during the reduction step results in the same colloidal stability as in the presence of OA but avoids erosion of the MNDs associated with OA. We introduce a thin mesoporous silica coating on the surface of hematite, effectively diminishing aggregation during reduction while allowing complete conversion into magnetite. This silica layer facilitates subsequent silane chemistry and the grafting of poly(N-isopropylacrylamide-co-methacrylic acid) P(NIPAM/MMA) coatings with 80 : 20 and 50 : 50 ratios, yielding highly stable aqueous suspensions of MNDs, both in aqueous and cell culture media. These findings establish a versatile pathway toward colloidally stable MNDs, thereby broadening their applicability in biomedical research.

26 August 2025 in RSC Pharmaceutics
Verified
Journal Article
Open access
PDF file
STSunissa Thongsom
Sunissa Thongsom
PGPaolo Di Gianvincenzo
Paolo Di Gianvincenzo
GCGiulia Ciattaglia
Giulia Ciattaglia
ASAhmed Subrati
Ahmed Subrati
DDDesiré DiSilvio
Desiré DiSilvio
SMSergio Moya
Sergio Moya
Nanosponges, exploiting hydrophilic and hydrophobic sites, were co-loaded with doxorubicin and EMD, resulting in a synergistic apoptotic effect in cancer cells, not observed for free co-delivery or separate encapsulation of the two drugs.

14 October 2026 in Colloids and Interfaces
Verified
Journal Article
Open access
PDF file
LDLUCREZIA DESIDERIO
LUCREZIA DESIDERIO
PGPaolo Di Gianvincenzo
Paolo Di Gianvincenzo
DSDesirè Di Silvio
Desirè Di Silvio
STSunisa Thongsom
Sunisa Thongsom
AOAlessio Olivieri
Alessio Olivieri
MGMauro Giustini
Mauro Giustini
Doxorubicin hydrochloride (DX) is a widely used chemotherapeutic agent whose severe side effects can be attenuated by suitably designing drug delivery systems. The complexation between DX and the biocompatible and biodegradable sodium alginate (ALG) results in the formation of DX@ALG nanoparticles under conditions where neither the drug nor the polymer tends to form nanoscopic structures. DX@ALG complex formation leads to the quenching of DX intrinsic fluorescence, and the drug shows chiroptical properties characteristic of supramolecular gels of DX. The association of DX and ALG into supramolecular nanoparticles takes place at low DX concentration and without salt addition. More than 99% of the moles of DX complexed with ALG form a gel-like phase, and DX@ALG nanoparticles show a high DX loading efficiency. Nanoparticle formation is revealed by Dynamic Light Scattering (DLS) and Atomic Force Microscopy (AFM). Quantum Mechanics (QM) calculations support the formation of supramolecular DX-ALG aggregates by π–π stacking and hydrogen bonds. DX@ALG nanoparticles have been fully characterized by several spectroscopic techniques. Preliminary in vitro evaluation of DX@ALG toxicity revealed an antiproliferative activity against selected cancer cell lines.

3 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LDLUCREZIA DESIDERIO
LUCREZIA DESIDERIO
PGPaolo Di Gianvincenzo
Paolo Di Gianvincenzo
DSDesiré De Silvio
Desiré De Silvio
STSunisa Thongsom
Sunisa Thongsom
AOAlessio Olivieri
Alessio Olivieri
MGMauro Giustini
Mauro Giustini
Hypothesis: doxorubicin hydrochloride (DX) is a widely used chemotherapeutic agent whose severe side-effects can be attenuated by suitably designing drug delivery systems. With this aim, the complexation between DX and the biocompatible and biodegradable sodium alginate (ALG) is here proposed for DX encapsulation.Experiments: the synergistic interaction in water between DX and ALG led to the self-assembly of DX@ALG nanoparticles that have been characterized by several spectroscopic techniques, dynamic light scattering (DLS), atomic force microscopy (AFM) and quantum mechanics (QM) calculation. A preliminary survey of the in-vitro cell toxicity of DX@ALG is also reportedFindings: DX@ALG complexes formation result in the quenching of DX that shows chiroptical properties characteristic of supramolecular gels of DX. The association of DX and alginate into supramolecular nanoparticles takes place at low DX concentration and without salt addition. More than 80 % of DX complexed with alginate is forming a gel like phase, and complexes show a high DX load. Nanoparticle formation is revealed by DLS and AFM. QM calculations support the formation of supramolecular DX aggregates by π-π stacking and hydrogen bonds.